With epidermal growth factor (EGF) stimulation, expression of both PD-associated Parkin mutants (R42P and G328E) or Parkin knockdown results in increased PLCγ1 (phospholipase C gamma1) and elevated basal cytosolic Ca2+ levels. The gene discussed is PRKN; the disease is Parkinson disease.